JPRN-UMIN000004979已完成2 期
Efficacy and safety of Garenoxacin for the prevention in the patients with hematological malignancies after chemotherapy - Garenoxacin for the prevention in hematological malignancies
Gifu University Hospital0 个研究点目标入组 50 人开始时间: 2011年1月31日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)GRNX is obviously ineffective to the pathogen. 2)Patients with a history of allergy/severe adverse effect to quinolone antibacterial agents or garenoxacin 3)Allergic diathesis 4)Pregnancy/lactation 5)Age of 15 years or younger 6)Patient was received systemic antibacterial therapy within 14 days 7)Patients who are regarded as inadequate
研究者
相似试验
已完成
不适用
Clinical efficacy of garenoxacin for treatment of bacterial respiratory infection secondary to chronic respiratory diseaseJPRN-UMIN000016373Department of Medicine, Division of Allergology and Respiratory Medicine, Showa University School of Medicine120
未知
3 期
Phase III study of Garenoxacin in the treatment of community-acquired pneumonia- A randomized, multi-center, double-blind, double-dummy and comparative studyThe patients with community-acquired pneumoniaJPRN-jRCT2080221655Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)
招募中
不适用
Clinical study of Garenoxacin on male non-gonococcal urethritisJPRN-UMIN000014994Jikei university katsushika medical center,Department of urology50
已完成
4 期
A post marketing study to check safety of Garenoxacin in patients with bacterial respiratory infectioCTRI/2015/01/005354Glenmark Pharmaceuticals Ltd461
已完成
不适用
Efficacy and safety of GHX02 in the treatment of acute bronchitis and acute exacerbation of chronic bronchitisKCT0003665Daejeon Korean Medicine Hospital of Daejeon University117